Fosmidomycin and Clindamycin for Malaria Treatment
Author Information
Author(s): Na-Bangchang Kesara, Ruengweerayut Ronnatrai, Karbwang Juntra, Chauemung Anurak, Hutchinson David
Primary Institution: Faculty of Allied Health Sciences, Thammasat University, Pathumthani, Thailand
Hypothesis
The study investigates the pharmacokinetics of fosmidomycin when given alone and in combination with clindamycin in patients with acute uncomplicated falciparum malaria.
Conclusion
Combination therapy with fosmidomycin and clindamycin was highly effective with a 100% cure rate, while monotherapy had a cure rate of only 22%.
Supporting Evidence
- Combination therapy achieved a 100% cure rate.
- Monotherapy with fosmidomycin had a cure rate of only 22%.
- Both treatment regimens were well tolerated with no serious adverse events.
Takeaway
This study looked at how well two medicines work together to treat malaria. When used together, they worked much better than when used alone.
Methodology
Patients were treated with either fosmidomycin alone or in combination with clindamycin, and their blood and urine samples were analyzed for drug concentrations.
Potential Biases
Potential bias due to the open-label design of the study.
Limitations
The study was conducted in a specific geographic area, which may limit the generalizability of the results.
Participant Demographics
33 patients (15 Thais, 5 Karens, 13 Burmeses) aged 18-50 with acute uncomplicated malaria.
Statistical Information
P-Value
0.004
Confidence Interval
95% C.I.
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website